Vulnerabilities in coronavirus glycan shields despite extensive glycosylation

Vulnerabilities in coronavirus glycan shields despite extensive glycosylation

Severe acute respiratory syndrome (SARS) and Middle East respiratory syndrome (MERS) coronaviruses (CoVs) are zoonotic pathogens with high fatality rates and pandemic potential. Vaccine development focuses on the principal target of the neutralizing humoral immune response, the spike (S) glycoprotei...

ver descrição completa

Detalhes bibliográficos
Principais autores:	Watanabe, Y, Berndsen, ZT, Raghwani, J, Seabright, GE, Allen, JD, Pybus, OG, McLellan, JS, Wilson, IA, Bowden, TA, Ward, AB, Crispin, M
Formato:	Journal article
Idioma:	English
Publicado em:	Springer Nature 2020

Registros relacionados

Vulnerabilities in coronavirus glycan shields despite extensive glycosylation
por: Yasunori Watanabe, et al.
Publicado em: (2020-05-01)

Structure of the Lassa virus glycan shield provides a model for immunological resistance
por: Watanabe, Y, et al.
Publicado em: (2018)

Antibodies expose multiple weaknesses in the glycan shield of HIV.
por: Crispin, M, et al.
Publicado em: (2013)

Antibodies expose multiple weaknesses in the glycan shield of HIV.
por: Crispin, M, et al.
Publicado em: (2013)

The impact of sequence diversity on the glycan shield of HIV-1 immunogens
por: Seabright, GE
Publicado em: (2019)

Beyond Shielding: The Roles of Glycans in the SARS-CoV‑2 Spike Protein
por: Lorenzo Casalino, et al.
Publicado em: (2020-09-01)

Glycan clustering stabilizes the mannose patch of HIV-1 and preserves vulnerability to broadly neutralizing antibodies.
por: Pritchard, L, et al.
Publicado em: (2015)

Architecture of the HIV-1 glycan shield
por: Pritchard, L
Publicado em: (2014)

Mapping the glycan shields of enveloped viruses
por: Watanabe, Y
Publicado em: (2020)

Integrity of glycosylation processing of a glycan-depleted trimeric HIV-1 immunogen targeting key B-cell lineages
por: Behrens, AJ, et al.
Publicado em: (2018)

The diversity of the glycan shield of sarbecoviruses related to SARS-CoV-2
por: Joel D. Allen, et al.
Publicado em: (2023-04-01)

The glycan shield of HIV is predominantly oligomannose independently of production system or viral clade.
por: Bonomelli, C, et al.
Publicado em: (2011)

Glycosylator: a Python framework for the rapid modeling of glycans
por: Thomas Lemmin, et al.
Publicado em: (2019-10-01)

N- and O-glycan analysis for the detection of glycosylation disorders
por: Amr Sobhi Gouda, et al.
Publicado em: (2021-01-01)

Immune recruitment or suppression by glycan engineering of endogenous and therapeutic antibodies
por: Le, N, et al.
Publicado em: (2016)

The glycan shield of HIV is predominantly oligomannose independently of production system or viral clade.
por: Camille Bonomelli, et al.
Publicado em: (2011-01-01)

Fine structure of the HIV-1 glycan shield
por: Behrens, A
Publicado em: (2017)

Glycan shield of the ebolavirus envelope glycoprotein GP
por: Weiwei Peng, et al.
Publicado em: (2022-08-01)

Conformational Heterogeneity of the HIV Envelope Glycan Shield
por: Mingjun Yang, et al.
Publicado em: (2017-06-01)

Glycan Nanostructures of Human Coronaviruses
por: Guo W, et al.
Publicado em: (2021-07-01)

Arenavirus glycan shield promotes neutralizing antibody evasion and protracted infection.
por: Sommerstein, R, et al.
Publicado em: (2015)

Arenavirus Glycan Shield Promotes Neutralizing Antibody Evasion and Protracted Infection.
por: Rami Sommerstein, et al.
Publicado em: (2015-11-01)

Synthesis of N-glycan oxazolines: donors for endohexosaminidase catalysed glycosylation.
por: Rising, T, et al.
Publicado em: (2006)

Editorial: Glycobiology and glycosylation: deciphering the secrets of glycans in humans and pathogens
por: Parham Jabbarzadeh Kaboli, et al.
Publicado em: (2025-02-01)

N-Glycosylation and N-Glycan Processing in HBV Biology and Pathogenesis
por: Mihaela-Olivia Dobrica, et al.
Publicado em: (2020-06-01)

Glycosylation network mapping and site-specific glycan maturation in vivo
por: Marie-Estelle Losfeld, et al.
Publicado em: (2022-11-01)

Recognition and penetration of the HIV-1 Env glycan shield by potent broadly neutralizing antibodies
por: Julien J, et al.
Publicado em: (2012-09-01)

Glycan Positioning Impacts HIV-1 Env Glycan-Shield Density, Function, and Recognition by Antibodies
por: Qing Wei, et al.
Publicado em: (2020-11-01)

Antibody evasion by a gammaherpesvirus O-glycan shield.
por: Bénédicte Machiels, et al.
Publicado em: (2011-11-01)

Glycan Profile Analysis of Engineered Trastuzumab with Rationally Added Glycosylation Sequons Presents Significantly Increased Glycan Complexity
por: Esteban Cruz, et al.
Publicado em: (2021-10-01)

Emerging COVID-19 coronavirus: glycan shield and structure prediction of spike glycoprotein and its interaction with human CD26
por: Naveen Vankadari, et al.
Publicado em: (2020-01-01)

A Potent and Broad Neutralizing Antibody Recognizes and Penetrates the HIV Glycan Shield
por: Pejchal, R, et al.
Publicado em: (2011)

Glycans instructing immunity: the emerging role of altered glycosylation in clinical immunology
por: Jonathan J Lyons, et al.
Publicado em: (2015-06-01)

Multivalent interactions between fully glycosylated influenza virus hemagglutinins mediated by glycans at distinct N-glycosylation sites
por: Ruofan Li, et al.
Publicado em: (2024-10-01)

Fine structure of the HIV-1 glycan shield - Supplementary information
por: Behrens, A
Publicado em: (2017)

Quantification of the Impact of the HIV-1-Glycan Shield on Antibody Elicitation
por: Tongqing Zhou, et al.
Publicado em: (2017-04-01)

Glycan Shielding and Modulation of Hepatitis C Virus Neutralizing Antibodies
por: Muriel Lavie, et al.
Publicado em: (2018-04-01)

Structural constraints determine the glycosylation of HIV-1 envelope trimers
por: Pritchard, L, et al.
Publicado em: (2015)

Glycan heterogeneity as a cause of the persistent fraction in HIV-1 neutralization.
por: Rajesh P Ringe, et al.
Publicado em: (2023-10-01)

Controlled site-selective protein glycosylation for precise glycan structure-catalytic activity relationships.
por: Davis, B, et al.
Publicado em: (2000)